Selected research
Industry Research
OTC Pain Medicines Industry Research Report 2026
Market perspective
The global OTC Pain Medicines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the OTC Pain Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the OTC Pain Medicines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the OTC Pain Medicines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of OTC Pain Medicines include Zhejiang Kangle, Xinhua Pharmaceutical, Sanofi, Novartis, Pfizer, Hebei Jiheng, GlaxoSmithKline, Bayer and Anhui BBCA Likang, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global OTC Pain Medicines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to OTC Pain Medicines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Pain Medicines Market by Company
Zhejiang Kangle
Xinhua Pharmaceutical
Sanofi
Novartis
Pfizer
Hebei Jiheng
GlaxoSmithKline
Bayer
Anhui BBCA Likang
Strides Shasun
Sri Krishna Pharma
Seqens
Mallinckrodt
IOLCP
Granules India
Granules Biocause
Farmson
Anqiu Lu'an
OTC Pain Medicines Segment by Type
Naproxen
Acetaminophen
Ibuprofen
Aspirin
Others
OTC Pain Medicines Segment by Application
E-Commerce
Drug Stores
Hospital Pharmacies
OTC Pain Medicines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Pain Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Pain Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Pain Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of OTC Pain Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Naproxen
- Acetaminophen
- Ibuprofen
- Aspirin
- Others
Applications
- E-Commerce
- Drug Stores
- Hospital Pharmacies
Companies covered
- Zhejiang Kangle
- Xinhua Pharmaceutical
- Sanofi
- Novartis
- Pfizer
- Hebei Jiheng
- GlaxoSmithKline
- Bayer
- Anhui BBCA Likang
- Strides Shasun
- Sri Krishna Pharma
- Seqens
- Mallinckrodt
- IOLCP
- Granules India
- Granules Biocause
- Farmson
- Anqiu Lu'an
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 OTC Pain Medicines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Naproxen
- 2.2.3 Acetaminophen
- 2.2.4 Ibuprofen
- 2.2.5 Aspirin
- 2.2.6 Others
- 2.3 OTC Pain Medicines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 E-Commerce
- 2.3.3 Drug Stores
- 2.3.4 Hospital Pharmacies
- 2.4 Assumptions and Limitations
3 OTC Pain Medicines Breakdown Data by Type
- 3.1 Global OTC Pain Medicines Historic Market Size by Type (2021-2026)
- 3.2 Global OTC Pain Medicines Forecasted Market Size by Type (2027-2032)
4 OTC Pain Medicines Breakdown Data by Application
- 4.1 Global OTC Pain Medicines Historic Market Size by Application (2021-2026)
- 4.2 Global OTC Pain Medicines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global OTC Pain Medicines Market Perspective (2021-2032)
- 5.2 Global OTC Pain Medicines Growth Trends by Region
- 5.2.1 Global OTC Pain Medicines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 OTC Pain Medicines Historic Market Size by Region (2021-2026)
- 5.2.3 OTC Pain Medicines Forecasted Market Size by Region (2027-2032)
- 5.3 OTC Pain Medicines Market Dynamics
- 5.3.1 OTC Pain Medicines Industry Trends
- 5.3.2 OTC Pain Medicines Market Drivers
- 5.3.3 OTC Pain Medicines Market Challenges
- 5.3.4 OTC Pain Medicines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top OTC Pain Medicines Players by Revenue
- 6.1.1 Global Top OTC Pain Medicines Players by Revenue (2021-2026)
- 6.1.2 Global OTC Pain Medicines Revenue Market Share by Players (2021-2026)
- 6.2 Global OTC Pain Medicines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of OTC Pain Medicines Head Office and Area Served
- 6.4 Global OTC Pain Medicines Players, Product Type & Application
- 6.5 Global OTC Pain Medicines Manufacturers Established Date
- 6.6 Global OTC Pain Medicines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America OTC Pain Medicines Market Size (2021-2032)
- 7.2 North America OTC Pain Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America OTC Pain Medicines Market Size by Country (2021-2026)
- 7.4 North America OTC Pain Medicines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe OTC Pain Medicines Market Size (2021-2032)
- 8.2 Europe OTC Pain Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe OTC Pain Medicines Market Size by Country (2021-2026)
- 8.4 Europe OTC Pain Medicines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific OTC Pain Medicines Market Size (2021-2032)
- 9.2 Asia-Pacific OTC Pain Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific OTC Pain Medicines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific OTC Pain Medicines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America OTC Pain Medicines Market Size (2021-2032)
- 10.2 South America OTC Pain Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America OTC Pain Medicines Market Size by Country (2021-2026)
- 10.4 South America OTC Pain Medicines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa OTC Pain Medicines Market Size (2021-2032)
- 11.2 Middle East & Africa OTC Pain Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa OTC Pain Medicines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa OTC Pain Medicines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zhejiang Kangle
- 12.1.1 Zhejiang Kangle Company Information
- 12.1.2 Zhejiang Kangle Business Overview
- 12.1.3 Zhejiang Kangle Revenue in OTC Pain Medicines Business (2021-2026)
- 12.1.4 Zhejiang Kangle OTC Pain Medicines Product Portfolio
- 12.1.5 Zhejiang Kangle Recent Developments
- 12.2 Xinhua Pharmaceutical
- 12.2.1 Xinhua Pharmaceutical Company Information
- 12.2.2 Xinhua Pharmaceutical Business Overview
- 12.2.3 Xinhua Pharmaceutical Revenue in OTC Pain Medicines Business (2021-2026)
- 12.2.4 Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio
- 12.2.5 Xinhua Pharmaceutical Recent Developments
- 12.3 Sanofi
- 12.3.1 Sanofi Company Information
- 12.3.2 Sanofi Business Overview
- 12.3.3 Sanofi Revenue in OTC Pain Medicines Business (2021-2026)
- 12.3.4 Sanofi OTC Pain Medicines Product Portfolio
- 12.3.5 Sanofi Recent Developments
- 12.4 Novartis
- 12.4.1 Novartis Company Information
- 12.4.2 Novartis Business Overview
- 12.4.3 Novartis Revenue in OTC Pain Medicines Business (2021-2026)
- 12.4.4 Novartis OTC Pain Medicines Product Portfolio
- 12.4.5 Novartis Recent Developments
- 12.5 Pfizer
- 12.5.1 Pfizer Company Information
- 12.5.2 Pfizer Business Overview
- 12.5.3 Pfizer Revenue in OTC Pain Medicines Business (2021-2026)
- 12.5.4 Pfizer OTC Pain Medicines Product Portfolio
- 12.5.5 Pfizer Recent Developments
- 12.6 Hebei Jiheng
- 12.6.1 Hebei Jiheng Company Information
- 12.6.2 Hebei Jiheng Business Overview
- 12.6.3 Hebei Jiheng Revenue in OTC Pain Medicines Business (2021-2026)
- 12.6.4 Hebei Jiheng OTC Pain Medicines Product Portfolio
- 12.6.5 Hebei Jiheng Recent Developments
- 12.7 GlaxoSmithKline
- 12.7.1 GlaxoSmithKline Company Information
- 12.7.2 GlaxoSmithKline Business Overview
- 12.7.3 GlaxoSmithKline Revenue in OTC Pain Medicines Business (2021-2026)
- 12.7.4 GlaxoSmithKline OTC Pain Medicines Product Portfolio
- 12.7.5 GlaxoSmithKline Recent Developments
- 12.8 Bayer
- 12.8.1 Bayer Company Information
- 12.8.2 Bayer Business Overview
- 12.8.3 Bayer Revenue in OTC Pain Medicines Business (2021-2026)
- 12.8.4 Bayer OTC Pain Medicines Product Portfolio
- 12.8.5 Bayer Recent Developments
- 12.9 Anhui BBCA Likang
- 12.9.1 Anhui BBCA Likang Company Information
- 12.9.2 Anhui BBCA Likang Business Overview
- 12.9.3 Anhui BBCA Likang Revenue in OTC Pain Medicines Business (2021-2026)
- 12.9.4 Anhui BBCA Likang OTC Pain Medicines Product Portfolio
- 12.9.5 Anhui BBCA Likang Recent Developments
- 12.10 Strides Shasun
- 12.10.1 Strides Shasun Company Information
- 12.10.2 Strides Shasun Business Overview
- 12.10.3 Strides Shasun Revenue in OTC Pain Medicines Business (2021-2026)
- 12.10.4 Strides Shasun OTC Pain Medicines Product Portfolio
- 12.10.5 Strides Shasun Recent Developments
- 12.11 Sri Krishna Pharma
- 12.11.1 Sri Krishna Pharma Company Information
- 12.11.2 Sri Krishna Pharma Business Overview
- 12.11.3 Sri Krishna Pharma Revenue in OTC Pain Medicines Business (2021-2026)
- 12.11.4 Sri Krishna Pharma OTC Pain Medicines Product Portfolio
- 12.11.5 Sri Krishna Pharma Recent Developments
- 12.12 Seqens
- 12.12.1 Seqens Company Information
- 12.12.2 Seqens Business Overview
- 12.12.3 Seqens Revenue in OTC Pain Medicines Business (2021-2026)
- 12.12.4 Seqens OTC Pain Medicines Product Portfolio
- 12.12.5 Seqens Recent Developments
- 12.13 Mallinckrodt
- 12.13.1 Mallinckrodt Company Information
- 12.13.2 Mallinckrodt Business Overview
- 12.13.3 Mallinckrodt Revenue in OTC Pain Medicines Business (2021-2026)
- 12.13.4 Mallinckrodt OTC Pain Medicines Product Portfolio
- 12.13.5 Mallinckrodt Recent Developments
- 12.14 IOLCP
- 12.14.1 IOLCP Company Information
- 12.14.2 IOLCP Business Overview
- 12.14.3 IOLCP Revenue in OTC Pain Medicines Business (2021-2026)
- 12.14.4 IOLCP OTC Pain Medicines Product Portfolio
- 12.14.5 IOLCP Recent Developments
- 12.15 Granules India
- 12.15.1 Granules India Company Information
- 12.15.2 Granules India Business Overview
- 12.15.3 Granules India Revenue in OTC Pain Medicines Business (2021-2026)
- 12.15.4 Granules India OTC Pain Medicines Product Portfolio
- 12.15.5 Granules India Recent Developments
- 12.16 Granules Biocause
- 12.16.1 Granules Biocause Company Information
- 12.16.2 Granules Biocause Business Overview
- 12.16.3 Granules Biocause Revenue in OTC Pain Medicines Business (2021-2026)
- 12.16.4 Granules Biocause OTC Pain Medicines Product Portfolio
- 12.16.5 Granules Biocause Recent Developments
- 12.17 Farmson
- 12.17.1 Farmson Company Information
- 12.17.2 Farmson Business Overview
- 12.17.3 Farmson Revenue in OTC Pain Medicines Business (2021-2026)
- 12.17.4 Farmson OTC Pain Medicines Product Portfolio
- 12.17.5 Farmson Recent Developments
- 12.18 Anqiu Lu'an
- 12.18.1 Anqiu Lu'an Company Information
- 12.18.2 Anqiu Lu'an Business Overview
- 12.18.3 Anqiu Lu'an Revenue in OTC Pain Medicines Business (2021-2026)
- 12.18.4 Anqiu Lu'an OTC Pain Medicines Product Portfolio
- 12.18.5 Anqiu Lu'an Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst